Liver Cancer Cell Lines
Database

LCCL to predict drug response

Drug: Sorafenib_Refametinib

DrugsAliasTargetsTargeted cellular functionClinical status in any tumor typeClinical status in HCCSupplierReference
Sorafenib_Refametinib BRAF, KDR, FLT4, PDGFRB, KIT, FLT3, RET and MEK1/2 Drug combination Selleck Chemicals S1040, S1089

Cell Line (34)
Cell LineAUCGI50
Huh7
HepG20.530.09
HepaRG0.610.29
JHH50.620.24
JHH10.630.33
HCC.1.20.680.54
SNU3870.711.03
SNU3980.722.11
JHH20.741.23
SNU8860.750.54
B10.770.99
HCC.30.792.31
Hep3B0.80.77
Huh60.81.5
JHH70.822.41


LCCL transcriptomic subgroup:
CL1
CL2
CL3
undef.

Codebase Soc. Coop.
info@codebase.it